{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:19:41Z","timestamp":1779891581556,"version":"3.53.1"},"reference-count":79,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82330094"],"award-info":[{"award-number":["82330094"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173265"],"award-info":[{"award-number":["82173265"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82072806"],"award-info":[{"award-number":["82072806"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Leading health talents of Shanghai Municipal Health Commission","award":["2022LJ002"],"award-info":[{"award-number":["2022LJ002"]}]},{"name":"Shanghai Leading Talent Program Project","award":["LJ2024013"],"award-info":[{"award-number":["LJ2024013"]}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"publisher","award":["23QC1401400"],"award-info":[{"award-number":["23QC1401400"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013105","name":"Shanghai Rising-Star Program","doi-asserted-by":"crossref","award":["23YF1458400"],"award-info":[{"award-number":["23YF1458400"]}],"id":[{"id":"10.13039\/501100013105","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100007219","name":"Natural Science Foundation of Shanghai Municipality","doi-asserted-by":"publisher","award":["23ZR1441300"],"award-info":[{"award-number":["23ZR1441300"]}],"id":[{"id":"10.13039\/100007219","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Hospital Funded Clinical Research, Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine","award":["21XHDB06"],"award-info":[{"award-number":["21XHDB06"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-025-06661-6","type":"journal-article","created":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T13:33:58Z","timestamp":1751376838000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Construction of a prostate adenocarcinoma molecular classification: integrating spatial transcriptomics with retrospective cohort validation"],"prefix":"10.1186","volume":"23","author":[{"given":"Bingnan","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuntao","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolin","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keqin","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junzhe","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runzhi","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinming","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuwu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0920-9439","authenticated-orcid":false,"given":"Xingang","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,1]]},"reference":[{"issue":"3","key":"6661_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung H, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209\u201349.","journal-title":"CA Cancer J Clin"},{"issue":"10305","key":"6661_CR2","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/S0140-6736(21)00950-8","volume":"398","author":"S Sandhu","year":"2021","unstructured":"Sandhu S, et al. Prostate cancer. Lancet. 2021;398(10305):1075\u201390.","journal-title":"Lancet"},{"issue":"17","key":"6661_CR3","doi-asserted-by":"publisher","first-page":"4948","DOI":"10.1158\/0008-5472.CAN-16-0902","volume":"76","author":"S You","year":"2016","unstructured":"You S, et al. Integrated classification of prostate cancer reveals a novel luminal subtype with poor outcome. Cancer Res. 2016;76(17):4948\u201358.","journal-title":"Cancer Res"},{"issue":"1","key":"6661_CR4","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1186\/s40880-019-0425-1","volume":"39","author":"X Zhang","year":"2019","unstructured":"Zhang X. Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer. Cancer Commun. 2019;39(1):76.","journal-title":"Cancer Commun"},{"issue":"3","key":"6661_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.eururo.2020.11.021","volume":"79","author":"NK Jairath","year":"2021","unstructured":"Jairath NK, et al. A systematic review of the evidence for the decipher genomic classifier in prostate cancer. Eur Urol. 2021;79(3):374\u201383.","journal-title":"Eur Urol"},{"issue":"1","key":"6661_CR6","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1016\/j.eururo.2014.11.038","volume":"69","author":"S Sommariva","year":"2016","unstructured":"Sommariva S, et al. Prognostic value of the cell cycle progression score in patients with prostate cancer: a systematic review and meta-analysis. Eur Urol. 2016;69(1):107\u201315.","journal-title":"Eur Urol"},{"issue":"2","key":"6661_CR7","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1016\/j.euf.2021.03.015","volume":"8","author":"M Covas Moschovas","year":"2022","unstructured":"Covas Moschovas M, et al. Association between oncotype DX genomic prostate score and adverse tumor pathology after radical prostatectomy. Eur Urol Focus. 2022;8(2):418\u201324.","journal-title":"Eur Urol Focus"},{"issue":"10","key":"6661_CR8","doi-asserted-by":"publisher","first-page":"1067","DOI":"10.6004\/jnccn.2023.0050","volume":"21","author":"EM Schaeffer","year":"2023","unstructured":"Schaeffer EM, et al. Prostate cancer, version 4.2023, NCCN clinical practice guidelines in oncology. J Natl Compr Canc Netw. 2023;21(10):1067\u201396.","journal-title":"J Natl Compr Canc Netw"},{"key":"6661_CR9","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.mam.2017.07.003","volume":"59","author":"E Hedlund","year":"2018","unstructured":"Hedlund E, Deng Q. Single-cell RNA sequencing: technical advancements and biological applications. Mol Aspects Med. 2018;59:36\u201346.","journal-title":"Mol Aspects Med"},{"key":"6661_CR10","first-page":"6837849","volume":"2022","author":"P Guan","year":"2022","unstructured":"Guan P, et al. Intercellular communication-related molecular subtypes and a gene signature identified by the single-cell RNA sequencing combined with a transcriptomic analysis. Dis Mark. 2022;2022:6837849.","journal-title":"Dis Mark"},{"issue":"11","key":"6661_CR11","doi-asserted-by":"publisher","first-page":"2195","DOI":"10.1002\/1878-0261.13190","volume":"16","author":"T Wang","year":"2022","unstructured":"Wang T, et al. Integrating bulk and single-cell RNA sequencing reveals cellular heterogeneity and immune infiltration in hepatocellular carcinoma. Mol Oncol. 2022;16(11):2195\u2013213.","journal-title":"Mol Oncol"},{"issue":"6294","key":"6661_CR12","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1126\/science.aaf2403","volume":"353","author":"PL St\u00e5hl","year":"2016","unstructured":"St\u00e5hl PL, et al. Visualization and analysis of gene expression in tissue sections by spatial transcriptomics. Science. 2016;353(6294):78\u201382.","journal-title":"Science"},{"issue":"10","key":"6661_CR13","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1038\/s41576-021-00370-8","volume":"22","author":"SK Longo","year":"2021","unstructured":"Longo SK, et al. Integrating single-cell and spatial transcriptomics to elucidate intercellular tissue dynamics. Nat Rev Genet. 2021;22(10):627\u201344.","journal-title":"Nat Rev Genet"},{"issue":"1","key":"6661_CR14","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1158\/2159-8290.CD-21-1059","volume":"12","author":"D Hanahan","year":"2022","unstructured":"Hanahan D. Hallmarks of cancer: new dimensions. Cancer Discov. 2022;12(1):31\u201346.","journal-title":"Cancer Discov"},{"issue":"1","key":"6661_CR15","first-page":"9","volume":"70","author":"WJ Mackillop","year":"1983","unstructured":"Mackillop WJ, et al. A stem cell model of human tumor growth: implications for tumor cell clonogenic assays. J Natl Cancer Inst. 1983;70(1):9\u201316.","journal-title":"J Natl Cancer Inst"},{"issue":"12","key":"6661_CR16","doi-asserted-by":"publisher","first-page":"108429","DOI":"10.1016\/j.isci.2023.108429","volume":"26","author":"Y Quan","year":"2023","unstructured":"Quan Y, et al. Visium spatial transcriptomics reveals intratumor heterogeneity and profiles of Gleason score progression in prostate cancer. iScience. 2023;26(12):108429.","journal-title":"iScience"},{"issue":"7667","key":"6661_CR17","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1038\/nature23306","volume":"548","author":"DR Robinson","year":"2017","unstructured":"Robinson DR, et al. Integrative clinical genomics of metastatic cancer. Nature. 2017;548(7667):297\u2013303.","journal-title":"Nature"},{"issue":"9","key":"6661_CR18","doi-asserted-by":"publisher","first-page":"1427","DOI":"10.1038\/s43018-024-00820-2","volume":"5","author":"B Dong","year":"2024","unstructured":"Dong B, et al. Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers. Nature Cancer. 2024;5(9):1427\u201347.","journal-title":"Nature Cancer"},{"issue":"D1","key":"6661_CR19","doi-asserted-by":"publisher","first-page":"D729","DOI":"10.1093\/nar\/gky1094","volume":"47","author":"R Zheng","year":"2019","unstructured":"Zheng R, et al. Cistrome data browser: expanded datasets and new tools for gene regulatory analysis. Nucleic Acids Res. 2019;47(D1):D729-d735.","journal-title":"Nucleic Acids Res"},{"issue":"2\u20133","key":"6661_CR20","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1007\/s12026-014-8516-1","volume":"58","author":"S Bhattacharya","year":"2014","unstructured":"Bhattacharya S, et al. ImmPort: disseminating data to the public for the future of immunology. Immunol Res. 2014;58(2\u20133):234\u20139.","journal-title":"Immunol Res"},{"issue":"3","key":"6661_CR21","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/s41587-019-0392-8","volume":"38","author":"R Moncada","year":"2020","unstructured":"Moncada R, et al. Integrating microarray-based spatial transcriptomics and single-cell RNA-seq reveals tissue architecture in pancreatic ductal adenocarcinomas. Nat Biotechnol. 2020;38(3):333\u201342.","journal-title":"Nat Biotechnol"},{"issue":"8","key":"6661_CR22","doi-asserted-by":"publisher","first-page":"e20","DOI":"10.1182\/blood-2016-05-716480","volume":"128","author":"S Nestorowa","year":"2016","unstructured":"Nestorowa S, et al. A single-cell resolution map of mouse hematopoietic stem and progenitor cell differentiation. Blood. 2016;128(8):e20-31.","journal-title":"Blood"},{"issue":"6","key":"6661_CR23","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, et al. The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325.","journal-title":"Cell Syst"},{"key":"6661_CR24","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","volume":"14","author":"S H\u00e4nzelmann","year":"2013","unstructured":"H\u00e4nzelmann S, Castelo R, Guinney J. GSVA: gene set variation analysis for microarray and RNA-seq data. BMC Bioinformatics. 2013;14:7.","journal-title":"BMC Bioinformatics"},{"issue":"10","key":"6661_CR25","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","volume":"14","author":"X Qiu","year":"2017","unstructured":"Qiu X, et al. Reversed graph embedding resolves complex single-cell trajectories. Nat Methods. 2017;14(10):979\u201382.","journal-title":"Nat Methods"},{"issue":"1","key":"6661_CR26","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1186\/1471-2105-15-293","volume":"15","author":"P Bardou","year":"2014","unstructured":"Bardou P, et al. jvenn: an interactive Venn diagram viewer. BMC Bioinformatics. 2014;15(1):293.","journal-title":"BMC Bioinformatics"},{"issue":"12","key":"6661_CR27","doi-asserted-by":"publisher","first-page":"1572","DOI":"10.1093\/bioinformatics\/btq170","volume":"26","author":"MD Wilkerson","year":"2010","unstructured":"Wilkerson MD, Hayes DN. ConsensusClusterPlus: a class discovery tool with confidence assessments and item tracking. Bioinformatics. 2010;26(12):1572\u20133.","journal-title":"Bioinformatics"},{"issue":"5","key":"6661_CR28","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/ng0506-500","volume":"38","author":"M Reich","year":"2006","unstructured":"Reich M, et al. GenePattern 2.0. Nat Genet. 2006;38(5):500\u20131.","journal-title":"Nat Genet"},{"issue":"1","key":"6661_CR29","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1016\/j.celrep.2016.12.019","volume":"18","author":"P Charoentong","year":"2017","unstructured":"Charoentong P, et al. Pan-cancer immunogenomic analyses reveal genotype-immunophenotype relationships and predictors of response to checkpoint blockade. Cell Rep. 2017;18(1):248\u201362.","journal-title":"Cell Rep"},{"issue":"6","key":"6661_CR30","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0157022","volume":"11","author":"H Varet","year":"2016","unstructured":"Varet H, et al. SARTools: a DESeq2- and EdgeR-Based R pipeline for comprehensive differential analysis of RNA-Seq data. PLoS ONE. 2016;11(6): e0157022.","journal-title":"PLoS ONE"},{"key":"6661_CR31","doi-asserted-by":"publisher","DOI":"10.1126\/science.362.6413.415-k","author":"MR Corces","year":"2018","unstructured":"Corces MR, et al. The chromatin accessibility landscape of primary human cancers. Science. 2018. https:\/\/doi.org\/10.1126\/science.362.6413.415-k.","journal-title":"Science"},{"issue":"5","key":"6661_CR32","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1089\/omi.2011.0118","volume":"16","author":"G Yu","year":"2012","unstructured":"Yu G, et al. clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS. 2012;16(5):284\u20137.","journal-title":"OMICS"},{"issue":"D1","key":"6661_CR33","doi-asserted-by":"publisher","first-page":"D330","DOI":"10.1093\/nar\/gky1055","volume":"47","author":"TGO Resource","year":"2019","unstructured":"Resource TGO. 20 years and still GOing strong. Nucleic Acids Res. 2019;47(D1):D330-d338.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"6661_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa M, Goto S. KEGG: kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 2000;28(1):27\u201330.","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"6661_CR35","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1038\/nmeth.3337","volume":"12","author":"AM Newman","year":"2015","unstructured":"Newman AM, et al. Robust enumeration of cell subsets from tissue expression profiles. Nat Methods. 2015;12(5):453\u20137.","journal-title":"Nat Methods"},{"issue":"2","key":"6661_CR36","doi-asserted-by":"publisher","first-page":"100398","DOI":"10.1016\/j.modpat.2023.100398","volume":"37","author":"Z Wen","year":"2023","unstructured":"Wen Z, et al. Deep learning-based H-score quantification of immunohistochemistry-stained images. Mod Pathol. 2023;37(2):100398.","journal-title":"Mod Pathol"},{"issue":"15","key":"6661_CR37","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1056\/NEJMoa041318","volume":"351","author":"DP Petrylak","year":"2004","unstructured":"Petrylak DP, et al. Docetaxel and estramustine compared with mitoxantrone and prednisone for advanced refractory prostate cancer. N Engl J Med. 2004;351(15):1513\u201320.","journal-title":"N Engl J Med"},{"issue":"22","key":"6661_CR38","doi-asserted-by":"publisher","first-page":"6354","DOI":"10.1158\/0008-5472.CAN-18-0687","volume":"78","author":"JW Russo","year":"2018","unstructured":"Russo JW, et al. Downregulation of dipeptidyl peptidase 4 accelerates progression to castration-resistant prostate cancer. Cancer Res. 2018;78(22):6354\u201362.","journal-title":"Cancer Res"},{"issue":"17","key":"6661_CR39","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1111\/jcmm.17845","volume":"27","author":"YC Wen","year":"2023","unstructured":"Wen YC, et al. Genetic variants of dipeptidyl peptidase IV are linked to the clinicopathologic development of prostate cancer. J Cell Mol Med. 2023;27(17):2507\u201316.","journal-title":"J Cell Mol Med"},{"issue":"11","key":"6661_CR40","doi-asserted-by":"publisher","first-page":"3082","DOI":"10.1074\/mcp.M114.038836","volume":"13","author":"A Nazarian","year":"2014","unstructured":"Nazarian A, et al. Inhibition of circulating dipeptidyl peptidase 4 activity in patients with metastatic prostate cancer. Mol Cell Proteomics. 2014;13(11):3082\u201396.","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"6661_CR41","doi-asserted-by":"publisher","first-page":"18936","DOI":"10.1038\/s41598-021-98410-0","volume":"11","author":"QK Li","year":"2021","unstructured":"Li QK, et al. Proteomic characterization of primary and metastatic prostate cancer reveals reduced proteinase activity in aggressive tumors. Sci Rep. 2021;11(1):18936.","journal-title":"Sci Rep"},{"issue":"4","key":"6661_CR42","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1158\/0008-5472.CAN-04-1852","volume":"65","author":"UV Wesley","year":"2005","unstructured":"Wesley UV, McGroarty M, Homoyouni A. Dipeptidyl peptidase inhibits malignant phenotype of prostate cancer cells by blocking basic fibroblast growth factor signaling pathway. Cancer Res. 2005;65(4):1325\u201334.","journal-title":"Cancer Res"},{"issue":"7","key":"6661_CR43","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1007\/s10585-008-9188-9","volume":"25","author":"YX Sun","year":"2008","unstructured":"Sun YX, et al. CD26\/dipeptidyl peptidase IV regulates prostate cancer metastasis by degrading SDF-1\/CXCL12. Clin Exp Metastasis. 2008;25(7):765\u201376.","journal-title":"Clin Exp Metastasis"},{"issue":"1","key":"6661_CR44","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13578-020-00517-w","volume":"11","author":"Y Zhao","year":"2021","unstructured":"Zhao Y, et al. Identification of predictors based on drug targets highlights accurate treatment of goserelin in breast and prostate cancer. Cell Biosci. 2021;11(1):5.","journal-title":"Cell Biosci"},{"issue":"1","key":"6661_CR45","doi-asserted-by":"publisher","DOI":"10.1080\/2162402X.2018.1486953","volume":"8","author":"K Hagihara","year":"2019","unstructured":"Hagihara K, et al. Neoadjuvant sipuleucel-T induces both Th1 activation and immune regulation in localized prostate cancer. Oncoimmunology. 2019;8(1): e1486953.","journal-title":"Oncoimmunology"},{"issue":"5","key":"6661_CR46","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1056\/NEJMoa1001294","volume":"363","author":"PW Kantoff","year":"2010","unstructured":"Kantoff PW, et al. Sipuleucel-T immunotherapy for castration-resistant prostate cancer. N Engl J Med. 2010;363(5):411\u201322.","journal-title":"N Engl J Med"},{"issue":"1","key":"6661_CR47","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1002\/pros.2990120106","volume":"12","author":"PA Abrahamsson","year":"1988","unstructured":"Abrahamsson PA, et al. Immunohistochemical distribution of the three predominant secretory proteins in the parenchyma of hyperplastic and neoplastic prostate glands. Prostate. 1988;12(1):39\u201346.","journal-title":"Prostate"},{"issue":"2","key":"6661_CR48","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1002\/(SICI)1097-0045(19991001)41:2<99::AID-PROS4>3.0.CO;2-C","volume":"41","author":"PS Chan","year":"1999","unstructured":"Chan PS, et al. In situ hybridization study of PSP94 (prostatic secretory protein of 94 amino acids) expression in human prostates. Prostate. 1999;41(2):99\u2013109.","journal-title":"Prostate"},{"issue":"5","key":"6661_CR49","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1016\/S0022-5347(05)67113-3","volume":"164","author":"Y Imasato","year":"2000","unstructured":"Imasato Y, et al. PSP94 expression after androgen deprivation therapy: a comparative study with prostate specific antigen in benign prostate and prostate cancer. J Urol. 2000;164(5):1819\u201324.","journal-title":"J Urol"},{"issue":"10","key":"6661_CR50","doi-asserted-by":"publisher","first-page":"2639","DOI":"10.1158\/1055-9965.EPI-10-0427","volume":"19","author":"KM Waters","year":"2010","unstructured":"Waters KM, et al. A common prostate cancer risk variant 5\u2019 of microseminoprotein-beta (MSMB) is a strong predictor of circulating beta-microseminoprotein (MSP) levels in multiple populations. Cancer Epidemiol Biomarkers Prev. 2010;19(10):2639\u201346.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"issue":"10","key":"6661_CR51","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1002\/pros.21149","volume":"70","author":"B Xu","year":"2010","unstructured":"Xu B, et al. A functional polymorphism in MSMB gene promoter is associated with prostate cancer risk and serum MSMB expression. Prostate. 2010;70(10):1146\u201352.","journal-title":"Prostate"},{"issue":"5","key":"6661_CR52","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1158\/1078-0432.CCR-10-0881","volume":"17","author":"J Ahn","year":"2011","unstructured":"Ahn J, et al. Prostate cancer predisposition loci and risk of metastatic disease and prostate cancer recurrence. Clin Cancer Res. 2011;17(5):1075\u201381.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"6661_CR53","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1038\/ng.90","volume":"40","author":"RA Eeles","year":"2008","unstructured":"Eeles RA, et al. Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet. 2008;40(3):316\u201321.","journal-title":"Nat Genet"},{"issue":"3","key":"6661_CR54","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.91","volume":"40","author":"G Thomas","year":"2008","unstructured":"Thomas G, et al. Multiple loci identified in a genome-wide association study of prostate cancer. Nat Genet. 2008;40(3):310\u20135.","journal-title":"Nat Genet"},{"issue":"6","key":"6661_CR55","doi-asserted-by":"publisher","first-page":"983","DOI":"10.1093\/annonc\/mdz121","volume":"30","author":"K Smith Byrne","year":"2019","unstructured":"Smith Byrne K, et al. The role of plasma microseminoprotein-beta in prostate cancer: an observational nested case-control and Mendelian randomization study in the European prospective investigation into cancer and nutrition. Ann Oncol. 2019;30(6):983\u20139.","journal-title":"Ann Oncol"},{"issue":"3","key":"6661_CR56","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0150241","volume":"11","author":"L Sj\u00f6blom","year":"2016","unstructured":"Sj\u00f6blom L, et al. Microseminoprotein-beta expression in different stages of prostate cancer. PLoS ONE. 2016;11(3): e0150241.","journal-title":"PLoS ONE"},{"issue":"14","key":"6661_CR57","doi-asserted-by":"publisher","first-page":"4130","DOI":"10.1158\/1078-0432.CCR-06-3031","volume":"13","author":"AS Bjartell","year":"2007","unstructured":"Bjartell AS, et al. Association of cysteine-rich secretory protein 3 and beta-microseminoprotein with outcome after radical prostatectomy. Clin Cancer Res. 2007;13(14):4130\u20138.","journal-title":"Clin Cancer Res"},{"issue":"5","key":"6661_CR58","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1038\/modpathol.2010.238","volume":"24","author":"A Dahlman","year":"2011","unstructured":"Dahlman A, et al. Evaluation of the prognostic significance of MSMB and CRISP3 in prostate cancer using automated image analysis. Mod Pathol. 2011;24(5):708\u201319.","journal-title":"Mod Pathol"},{"issue":"4","key":"6661_CR59","first-page":"1582","volume":"13","author":"X Chen","year":"2023","unstructured":"Chen X, et al. Identification and validation of MSMB as a critical gene for prostate cancer development in obese people. Am J Cancer Res. 2023;13(4):1582\u201393.","journal-title":"Am J Cancer Res"},{"key":"6661_CR60","doi-asserted-by":"publisher","first-page":"100115","DOI":"10.1016\/j.mcpro.2021.100115","volume":"20","author":"Y Gong","year":"2021","unstructured":"Gong Y, et al. Age-associated proteomic signatures and potential clinically actionable targets of colorectal cancer. Mol Cell Proteomics. 2021;20:100115.","journal-title":"Mol Cell Proteomics"},{"issue":"2","key":"6661_CR61","doi-asserted-by":"publisher","first-page":"626","DOI":"10.3390\/ijms23020626","volume":"23","author":"L Button","year":"2022","unstructured":"Button L, et al. Telomere and telomerase-associated proteins in endometrial carcinogenesis and cancer-associated survival. Int J Mol Sci. 2022;23(2):626.","journal-title":"Int J Mol Sci"},{"issue":"3","key":"6661_CR62","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.bbrc.2011.12.101","volume":"417","author":"J Her","year":"2012","unstructured":"Her J, Chung IK. The AAA-ATPase NVL2 is a telomerase component essential for holoenzyme assembly. Biochem Biophys Res Commun. 2012;417(3):1086\u201392.","journal-title":"Biochem Biophys Res Commun"},{"issue":"7","key":"6661_CR63","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.1158\/1078-0432.CCR-15-1250","volume":"22","author":"SG Zhao","year":"2016","unstructured":"Zhao SG, et al. The landscape of prognostic outlier genes in high-risk prostate cancer. Clin Cancer Res. 2016;22(7):1777\u201386.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"6661_CR64","doi-asserted-by":"publisher","first-page":"1863","DOI":"10.1172\/JCI111148","volume":"72","author":"RS Adelstein","year":"1983","unstructured":"Adelstein RS. Regulation of contractile proteins by phosphorylation. J Clin Invest. 1983;72(6):1863\u20136.","journal-title":"J Clin Invest"},{"key":"6661_CR65","doi-asserted-by":"publisher","first-page":"110665","DOI":"10.1016\/j.biopha.2020.110665","volume":"131","author":"F Cao","year":"2020","unstructured":"Cao F, et al. Myosin light chain kinase is a potential target for hypopharyngeal cancer treatment. Biomed Pharmacother. 2020;131:110665.","journal-title":"Biomed Pharmacother"},{"key":"6661_CR66","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1016\/j.fct.2013.10.028","volume":"62","author":"L Zuo","year":"2013","unstructured":"Zuo L, et al. Butyrate suppresses proliferation and migration of RKO colon cancer cells though regulating endocan expression by MAPK signaling pathway. Food Chem Toxicol. 2013;62:892\u2013900.","journal-title":"Food Chem Toxicol"},{"issue":"13","key":"6661_CR67","doi-asserted-by":"publisher","first-page":"2558","DOI":"10.1002\/1878-0261.13208","volume":"16","author":"X Shi","year":"2022","unstructured":"Shi X, et al. SIK2 promotes ovarian cancer cell motility and metastasis by phosphorylating MYLK. Mol Oncol. 2022;16(13):2558\u201374.","journal-title":"Mol Oncol"},{"issue":"7","key":"6661_CR68","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1016\/j.ejca.2005.12.017","volume":"42","author":"LZ Gu","year":"2006","unstructured":"Gu LZ, et al. Inhibiting myosin light chain kinase retards the growth of mammary and prostate cancer cells. Eur J Cancer. 2006;42(7):948\u201357.","journal-title":"Eur J Cancer"},{"issue":"6799","key":"6661_CR69","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1038\/35023024","volume":"406","author":"H Yin","year":"2000","unstructured":"Yin H, et al. Myosin V orientates the mitotic spindle in yeast. Nature. 2000;406(6799):1013\u20135.","journal-title":"Nature"},{"issue":"5536","key":"6661_CR70","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1126\/science.1062257","volume":"293","author":"H Puthalakath","year":"2001","unstructured":"Puthalakath H, et al. Bmf: a proapoptotic BH3-only protein regulated by interaction with the myosin V actin motor complex, activated by anoikis. Science. 2001;293(5536):1829\u201332.","journal-title":"Science"},{"issue":"29","key":"6661_CR71","doi-asserted-by":"publisher","first-page":"4183","DOI":"10.1038\/onc.2010.165","volume":"29","author":"Q Wu","year":"2010","unstructured":"Wu Q, et al. Deficiency in myosin light-chain phosphorylation causes cytokinesis failure and multipolarity in cancer cells. Oncogene. 2010;29(29):4183\u201393.","journal-title":"Oncogene"},{"issue":"3","key":"6661_CR72","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1073\/pnas.0304146101","volume":"101","author":"J Lapointe","year":"2004","unstructured":"Lapointe J, et al. Gene expression profiling identifies clinically relevant subtypes of prostate cancer. Proc Natl Acad Sci U S A. 2004;101(3):811\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"6661_CR73","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/ng1060","volume":"33","author":"S Ramaswamy","year":"2003","unstructured":"Ramaswamy S, et al. A molecular signature of metastasis in primary solid tumors. Nat Genet. 2003;33(1):49\u201354.","journal-title":"Nat Genet"},{"issue":"2","key":"6661_CR74","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/S1535-6108(02)00030-2","volume":"1","author":"D Singh","year":"2002","unstructured":"Singh D, et al. Gene expression correlates of clinical prostate cancer behavior. Cancer Cell. 2002;1(2):203\u20139.","journal-title":"Cancer Cell"},{"key":"6661_CR75","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12935-018-0516-0","volume":"18","author":"RF Ivanovic","year":"2018","unstructured":"Ivanovic RF, et al. miR-29b enhances prostate cancer cell invasion independently of MMP-2 expression. Cancer Cell Int. 2018;18:18.","journal-title":"Cancer Cell Int"},{"issue":"10","key":"6661_CR76","doi-asserted-by":"publisher","first-page":"1751","DOI":"10.1038\/s41388-018-0540-5","volume":"38","author":"C Probert","year":"2019","unstructured":"Probert C, et al. Communication of prostate cancer cells with bone cells via extracellular vesicle RNA; a potential mechanism of metastasis. Oncogene. 2019;38(10):1751\u201363.","journal-title":"Oncogene"},{"key":"6661_CR77","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.canlet.2018.08.027","volume":"438","author":"C Delliaux","year":"2018","unstructured":"Delliaux C, et al. TMPRSS2:ERG gene fusion expression regulates bone markers and enhances the osteoblastic phenotype of prostate cancer bone metastases. Cancer Lett. 2018;438:32\u201343.","journal-title":"Cancer Lett"},{"issue":"8","key":"6661_CR78","doi-asserted-by":"publisher","first-page":"797","DOI":"10.1593\/neo.08380","volume":"10","author":"CL Hall","year":"2008","unstructured":"Hall CL, et al. Type I collagen receptor (alpha2beta1) signaling promotes prostate cancer invasion through RhoC GTPase. Neoplasia. 2008;10(8):797\u2013803.","journal-title":"Neoplasia"},{"issue":"6","key":"6661_CR79","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","volume":"11","author":"KN Weilbaecher","year":"2011","unstructured":"Weilbaecher KN, Guise TA, McCauley LK. Cancer to bone: a fatal attraction. Nat Rev Cancer. 2011;11(6):411\u201325.","journal-title":"Nat Rev Cancer"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06661-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-025-06661-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-025-06661-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,2]],"date-time":"2025-07-02T01:05:22Z","timestamp":1751418322000},"score":1,"resource":{"primary":{"URL":"https:\/\/translational-medicine.biomedcentral.com\/articles\/10.1186\/s12967-025-06661-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,1]]},"references-count":79,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["6661"],"URL":"https:\/\/doi.org\/10.1186\/s12967-025-06661-6","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,1]]},"assertion":[{"value":"19 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 May 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Our study was approved by the Ethics Committee of Xinhua Hospital Affiliated to Shanghai Jiao Tong University School of Medicine (XHEC-D-2023-047). All authors confirmed that the whole study was carried out in accordance with relevant guidelines.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that there is no conflict of interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"717"}}